Simone Cazzaniga

InstitutionCentro Studi GISED
AddressBergamo
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 9 Covid-19 publications, with a maximum of 1 publications in May 2020 and July 2020 and October 2020 and November 2020 and December 2020 and March 2021 and April 2021 and June 2021 and August 2021
    All Publications
    Bar chart showing 55 publications over 11 distinct years, with a maximum of 9 publications in 2016 and 2018
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Piaserico S, Gisondi P, Cazzaniga S, Di Leo S, Naldi L. Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence. J Invest Dermatol. 2022 02; 142(2):355-363.e7. PMID: 34363826.
      Citations:    Fields:    
    2. Gisondi P, Bellinato F, Piaserico S, Di Leo S, Cazzaniga S, Naldi L. Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs. Dermatol Ther (Heidelb). 2021 Aug; 11(4):1333-1343. PMID: 34173220.
      Citations:    
    3. Gisondi P, Di Leo S, Bellinato F, Cazzaniga S, Piaserico S, Naldi L. Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review. Dermatol Ther (Heidelb). 2021 Jun; 11(3):695-705. PMID: 33811315.
      Citations: 3     
    4. Piaserico S, Gisondi P, Cazzaniga S, Cazzaniga S, Girolomoni G, Girolomoni G, Calzavara-Pinton PG, Naldi L. Is SARS-CoV-2 screening test indicated for psoriasis patients candidate to biologic therapy? J Eur Acad Dermatol Venereol. 2021 Jun; 35(6):e355-e357. PMID: 33587774.
      Citations: 1     Fields:    Translation:Humans
    5. Cagnazzo C, Besse MG, Manfellotto D, Minghetti P, Cazzaniga S, Cazzaniga S, Cottini L, Fontanella A, Maruti I, Stabile S, Testoni S, Trogu P, Sinno V, Gussoni G. Lessons learned from COVID-19 for clinical research operations in Italy: what have we learned and what can we apply in the future? Tumori. 2021 Feb; 107(1):6-11. PMID: 33297885.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    6. Gisondi P, Piaserico S, Naldi L, Dapavo P, Conti A, Malagoli P, Marzano AV, Bardazzi F, Gasperini M, Cazzaniga S, Costanzo A. Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience. J Allergy Clin Immunol. 2021 Feb; 147(2):558-560.e1. PMID: 33160968.
      Citations: 13     Fields:    Translation:Humans
    7. Piaserico S, Gisondi P, Cazzaniga S, Naldi L. Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy. Am J Clin Dermatol. 2020 10; 21(5):749-751. PMID: 32812188.
      Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
    8. Naldi L, Cazzaniga S. More on Covid-19 in Immune-Mediated Inflammatory Diseases. N Engl J Med. 2020 08 20; 383(8):795-796. PMID: 32649068.
      Citations: 1     Fields:    Translation:HumansCellsPHPublic Health
    9. Gisondi P, Facheris P, Dapavo P, Piaserico S, Conti A, Naldi L, Cazzaniga S, Cazzaniga S, Malagoli P, Costanzo A. The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience. Br J Dermatol. 2020 08; 183(2):373-374. PMID: 32343839.
      Citations: 38     Fields:    Translation:HumansCellsPHPublic Health